China National Accord Medicines Corp Ltd (000028) - Total Liabilities
Based on the latest financial reports, China National Accord Medicines Corp Ltd (000028) has total liabilities worth CN¥29.01 Billion CNY (≈ $4.24 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
China National Accord Medicines Corp Ltd - Total Liabilities Trend (1992–2024)
This chart illustrates how China National Accord Medicines Corp Ltd's total liabilities have evolved over time, based on quarterly financial data. See how liquid is China National Accord Medicines Corp Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.
China National Accord Medicines Corp Ltd Competitors by Total Liabilities
The table below lists competitors of China National Accord Medicines Corp Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Graubuendner Kantonalbank
SW:GRKP
|
Switzerland | CHF33.30 Billion |
|
Zhejiang Runtu Co Ltd
SHE:002440
|
China | CN¥1.45 Billion |
|
Xenia Hotels & Resorts Inc
NYSE:XHR
|
USA | $1.64 Billion |
|
Premier Investments Ltd
AU:PMV
|
Australia | AU$432.10 Million |
|
Akzo Nobel India Limited
NSE:AKZOINDIA
|
India | Rs13.44 Billion |
|
Stagwell Inc
NASDAQ:STGW
|
USA | $3.50 Billion |
|
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SHE:300357
|
China | CN¥161.98 Million |
Liability Composition Analysis (1992–2024)
This chart breaks down China National Accord Medicines Corp Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of China National Accord Medicines Corp Ltd.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.50 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.57 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.57 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how China National Accord Medicines Corp Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for China National Accord Medicines Corp Ltd (1992–2024)
The table below shows the annual total liabilities of China National Accord Medicines Corp Ltd from 1992 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥26.80 Billion ≈ $3.92 Billion |
+0.78% |
| 2023-12-31 | CN¥26.59 Billion ≈ $3.89 Billion |
+14.77% |
| 2022-12-31 | CN¥23.17 Billion ≈ $3.39 Billion |
-6.42% |
| 2021-12-31 | CN¥24.76 Billion ≈ $3.62 Billion |
+9.05% |
| 2020-12-31 | CN¥22.71 Billion ≈ $3.32 Billion |
+25.03% |
| 2019-12-31 | CN¥18.16 Billion ≈ $2.66 Billion |
+20.87% |
| 2018-12-31 | CN¥15.02 Billion ≈ $2.20 Billion |
+21.01% |
| 2017-12-31 | CN¥12.42 Billion ≈ $1.82 Billion |
+0.14% |
| 2016-12-31 | CN¥12.40 Billion ≈ $1.81 Billion |
+62.04% |
| 2015-12-31 | CN¥7.65 Billion ≈ $1.12 Billion |
-4.08% |
| 2014-12-31 | CN¥7.98 Billion ≈ $1.17 Billion |
-8.73% |
| 2013-12-31 | CN¥8.74 Billion ≈ $1.28 Billion |
+17.23% |
| 2012-12-31 | CN¥7.46 Billion ≈ $1.09 Billion |
+19.52% |
| 2011-12-31 | CN¥6.24 Billion ≈ $912.96 Million |
+20.55% |
| 2010-12-31 | CN¥5.18 Billion ≈ $757.32 Million |
+18.83% |
| 2009-12-31 | CN¥4.36 Billion ≈ $637.33 Million |
+43.52% |
| 2008-12-31 | CN¥3.03 Billion ≈ $444.06 Million |
+27.05% |
| 2007-12-31 | CN¥2.39 Billion ≈ $349.51 Million |
+8.26% |
| 2006-12-31 | CN¥2.21 Billion ≈ $322.86 Million |
+225.07% |
| 2005-12-31 | CN¥678.73 Million ≈ $99.32 Million |
+39.09% |
| 2004-12-31 | CN¥487.99 Million ≈ $71.41 Million |
-26.67% |
| 2003-12-31 | CN¥665.47 Million ≈ $97.38 Million |
-7.30% |
| 2002-12-31 | CN¥717.90 Million ≈ $105.05 Million |
-4.75% |
| 2001-12-31 | CN¥753.72 Million ≈ $110.29 Million |
+778.18% |
| 2000-12-31 | CN¥85.83 Million ≈ $12.56 Million |
-1.03% |
| 1999-12-31 | CN¥86.72 Million ≈ $12.69 Million |
-24.01% |
| 1998-12-31 | CN¥114.11 Million ≈ $16.70 Million |
-31.94% |
| 1997-12-31 | CN¥167.66 Million ≈ $24.53 Million |
+87.37% |
| 1996-12-31 | CN¥89.48 Million ≈ $13.09 Million |
+77.00% |
| 1995-12-31 | CN¥50.55 Million ≈ $7.40 Million |
-11.09% |
| 1994-12-31 | CN¥56.85 Million ≈ $8.32 Million |
-41.32% |
| 1993-12-31 | CN¥96.88 Million ≈ $14.18 Million |
+4.01% |
| 1992-12-31 | CN¥93.14 Million ≈ $13.63 Million |
-- |
About China National Accord Medicines Corp Ltd
China National Accord Medicines Corporation Ltd. engages in the retail and distribution of pharmaceutical products in China and internationally. The company offers prescription drugs for various illnesses and medications requiring long-term use, such as oncology, liver disease, neurology, psychiatry, cardiovascular, and rheumatology/immunology. It also provides traditional Chinese medicine, Weste… Read more